Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors

被引:236
作者
Blankson, Joel N.
Bailey, Justin R.
Thayil, Seema
Yang, Hung-Chih
Lassen, Kara
Lai, Jun
Gandhi, Shiv K.
Siliciano, Janet D.
Williams, Thomas M.
Siliciano, Robert F.
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Howard Hughes Med Inst, Baltimore, MD 21205 USA
[3] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA
[4] Tricore Reference Labs, Albuquerque, NM 87131 USA
关键词
D O I
10.1128/JVI.02165-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Elite suppressors (ES) are untreated human immunodeficiency virus type I (HIV-1)-infected individuals who control viremia to levels below the limit of detection of current assays. The mechanisms involved in this control have not been fully elucidated. Several studies have demonstrated that some ES are infected with defective viruses, but it remains unclear whether others are infected with replication-competent HIV-1. To answer this question, we used a sensitive coculture assay in an attempt to isolate replication-competent virus from a cohort of 10 ES. We successfully cultured six replication-competent isolates from 4 of the 10 ES. The frequency of latently infected cells in these patients was more than a log lower than that seen in patients on highly active antiretroviral therapy with undetectable viral loads. Full-length sequencing of all six isolates revealed no large deletions in any of the genes. A few mutations and small insertions and deletions were found in some isolates, but phenotypic analysis of the affected genes suggested that their function remained intact. Furthermore, all six isolates replicated as well as standard laboratory strains in vitro. The results suggest that some ES are infected with HIV-1 isolates that are fully replication competent and that long-term immunologic control of replication-competent HIV-1 is possible.
引用
收藏
页码:2508 / 2518
页数:11
相关论文
共 60 条
[1]   Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load [J].
Addo, MM ;
Yu, XG ;
Rathod, A ;
Cohen, D ;
Eldridge, RL ;
Strick, D ;
Johnston, MN ;
Corcoran, C ;
Wurcel, AG ;
Fitzpatrick, CA ;
Feeney, ME ;
Rodriguez, WR ;
Basgoz, N ;
Draenert, R ;
Stone, DR ;
Brander, C ;
Goulder, PJR ;
Rosenberg, ES ;
Altfeld, M ;
Walker, BD .
JOURNAL OF VIROLOGY, 2003, 77 (03) :2081-2092
[2]   Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection [J].
Alexander, L ;
Weiskopf, E ;
Greenough, TC ;
Gaddis, NC ;
Auerbach, MR ;
Malim, MH ;
O'Brien, SJ ;
Walker, BD ;
Sullivan, JL ;
Desrosiers, RC .
JOURNAL OF VIROLOGY, 2000, 74 (09) :4361-4376
[3]   Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child [J].
Alexander, L ;
Aquino-DeJesus, MJ ;
Chan, M ;
Andiman, WA .
JOURNAL OF VIROLOGY, 2002, 76 (20) :10533-10539
[4]   Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations [J].
Bailey, Justin R. ;
Williams, Thomas M. ;
Siliciano, Robert F. ;
Blankson, Joel N. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (05) :1357-1369
[5]   Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy [J].
Bailey, Justin R. ;
Lassen, Kara G. ;
Yang, Hung-Chih ;
Quinn, Thomas C. ;
Ray, Stuart C. ;
Blankson, Joel N. ;
Siliciano, Robert F. .
JOURNAL OF VIROLOGY, 2006, 80 (10) :4758-4770
[6]   Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome [J].
Barker, E ;
Mackewicz, CE ;
Reyes-Terán, G ;
Sato, A ;
Stranford, SA ;
Fujimura, SH ;
Christopherson, C ;
Chang, SY ;
Levy, JA .
BLOOD, 1998, 92 (09) :3105-3114
[7]   Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection [J].
Betts, MR ;
Ambrozak, DR ;
Douek, DC ;
Bonhoeffer, S ;
Brenchley, JM ;
Casazza, JP ;
Koup, RA ;
Picker, LJ .
JOURNAL OF VIROLOGY, 2001, 75 (24) :11983-11991
[8]   Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors [J].
Bradney, AP ;
Scheer, S ;
Crawford, JM ;
Buchbinder, SP ;
Montefiori, DC .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05) :1264-1267
[9]   Progression of HIV: Follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985 [J].
Brettle, RP ;
McNeil, AJ ;
Burns, S ;
Gore, SM ;
Bird, AG ;
Yap, PL ;
MacCallum, L ;
Leen, CSL ;
Richardson, AM .
AIDS, 1996, 10 (04) :419-430
[10]   Entire genome of a strain of human immunodeficiency virus type 1 with a deletion of nef that was recovered 20 years after primary infection:: Large pool of proviruses with deletions of env [J].
Calugi, Graziella ;
Montella, Francesco ;
Favalli, Cartesio ;
Benedetto, Arrigo .
JOURNAL OF VIROLOGY, 2006, 80 (23) :11892-11896